The incidence rate of heart failure was 2- to 3-fold higher among American Indian populations than rates observed in studies ...

SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

Age, race, income level, obesity, and physical inactivity all contribute to the risk of being diagnosed with diabetes.

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study.

Each year, health care professionals in the Greater Charlotte area are nominated and selected as Health Care Heroes by the ...

Advances in AI have allowed researchers to use a short audio clip to detect diabetes with 66 percent accuracy in women and 71 ...

A small new study suggests that time-restricted eating could help improve blood sugar control in some people, thus ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

According to a study a class of diabetes medications may be linked to a decreased risk of dementia and Parkinson disease ...